Search research articles
Contact Us
Filters
Showing results (31-40 of 59) with videos related to
Page
of 6
Sort By:
Journal of Proteome Research
|
February 3, 2007
Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients
Fatima W Khwaja, Matthew S Reed, Jeffrey J Olson, et al.
Journal of Neuro-Oncology
|
April 28, 2006
Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: a relationship among efficacy, joint toxicity and anticonvulsant status
Morris D Groves, Vinay K Puduvalli, Charles A Conrad, et al.
Neuro-Oncology
|
May 29, 2014
Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials
Marc Chamberlain, Riccardo Soffietti, Jeffrey Raizer, et al.
Neuro-Oncology
|
January 1, 2017
Leptomeningeal metastases: a RANO proposal for response criteria
Marc Chamberlain, Larry Junck, Dieta Brandsma, et al.
Journal of Neuro-Oncology
|
July 24, 2010
Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma
Tobias Walbert, Mark R Gilbert, Morris D Groves, et al.
International Journal of Oncology
|
May 11, 2006
Synergistic effect and condition of pegylated interferon alpha with paclitaxel on glioblastoma
Myung Jin Son, Hyun Seok Song, Mi Hyun Kim, et al.
Neuro-Oncology
|
August 24, 2010
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma
Mark R Gilbert, Javier Gonzalez, Kathy Hunter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 2013
A phase I/II trial of pazopanib in combination with lapatinib in adult patients with relapsed malignant glioma
David A Reardon, Morris D Groves, Patrick Y Wen, et al.
Journal of Neuro-Oncology
|
June 8, 2020
Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer
Rachna Malani, Martin Fleisher, Priya Kumthekar, et al.
Cancer
|
November 17, 2011
Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma
Pierre Giglio, Megha Dhamne, Kenneth R Hess, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 59) with videos related to
Sort By:
Page
of 6
Journal of Proteome Research
|
February 3, 2007
Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients
Fatima W Khwaja, Matthew S Reed, Jeffrey J Olson, et al.
Journal of Neuro-Oncology
|
April 28, 2006
Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: a relationship among efficacy, joint toxicity and anticonvulsant status
Morris D Groves, Vinay K Puduvalli, Charles A Conrad, et al.
Neuro-Oncology
|
May 29, 2014
Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials
Marc Chamberlain, Riccardo Soffietti, Jeffrey Raizer, et al.
Neuro-Oncology
|
January 1, 2017
Leptomeningeal metastases: a RANO proposal for response criteria
Marc Chamberlain, Larry Junck, Dieta Brandsma, et al.
Journal of Neuro-Oncology
|
July 24, 2010
Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma
Tobias Walbert, Mark R Gilbert, Morris D Groves, et al.
International Journal of Oncology
|
May 11, 2006
Synergistic effect and condition of pegylated interferon alpha with paclitaxel on glioblastoma
Myung Jin Son, Hyun Seok Song, Mi Hyun Kim, et al.
Neuro-Oncology
|
August 24, 2010
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma
Mark R Gilbert, Javier Gonzalez, Kathy Hunter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 1, 2013
A phase I/II trial of pazopanib in combination with lapatinib in adult patients with relapsed malignant glioma
David A Reardon, Morris D Groves, Patrick Y Wen, et al.
Journal of Neuro-Oncology
|
June 8, 2020
Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer
Rachna Malani, Martin Fleisher, Priya Kumthekar, et al.
Cancer
|
November 17, 2011
Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma
Pierre Giglio, Megha Dhamne, Kenneth R Hess, et al.
Page
of 6